Industry Spotlight

There’s a new approval and head-to-head trial data for BRUKINSA® (zanubrutinib) now available

September 2021

There’s a new approval and head-to-head trial data for BRUKINSA® (zanubrutinib) now available

August 2021

QUZYTTIR® (cetirizine hydrochloride injection) 10mg/mL added to SAN contract

Cetirizine now included in CDC Guidelines for managing adverse reactions after COVID-19 vaccination

April 2021